Nurix Therapeutics, Inc. announced the appointment of Dr. Jason Kantor as senior vice president, finance and investment strategy. In this role, Dr. Kantor will be responsible for communicating the vision and value of Nurix’s platform, therapeutic programs and strategic initiatives and assist in capital formation. Prior to joining Nurix, he served as a senior biopharma analyst at Artisan Partners, where he covered industry trends for both large and small cap biotech and pharma companies globally.